Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181
Income Statement
Earnings Waterfall
Zhejiang Jolly Pharmaceutical Co Ltd
Revenue
|
2.1B
CNY
|
Cost of Revenue
|
-713.8m
CNY
|
Gross Profit
|
1.4B
CNY
|
Operating Expenses
|
-906.9m
CNY
|
Operating Income
|
499m
CNY
|
Other Expenses
|
-71.1m
CNY
|
Net Income
|
427.9m
CNY
|
Income Statement
Zhejiang Jolly Pharmaceutical Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
431
N/A
|
440
+2%
|
457
+4%
|
515
+13%
|
572
+11%
|
620
+8%
|
657
+6%
|
671
+2%
|
721
+7%
|
810
+12%
|
819
+1%
|
840
+3%
|
830
-1%
|
814
-2%
|
804
-1%
|
794
-1%
|
762
-4%
|
744
-2%
|
724
-3%
|
730
+1%
|
764
+5%
|
767
+0%
|
859
+12%
|
911
+6%
|
901
-1%
|
950
+5%
|
1 024
+8%
|
1 091
+7%
|
1 238
+13%
|
1 322
+7%
|
1 400
+6%
|
1 457
+4%
|
1 557
+7%
|
1 655
+6%
|
1 723
+4%
|
1 805
+5%
|
1 861
+3%
|
1 922
+3%
|
1 926
+0%
|
1 942
+1%
|
2 120
+9%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(61)
|
(60)
|
(67)
|
(90)
|
(127)
|
(155)
|
(185)
|
(211)
|
(256)
|
(301)
|
(329)
|
(340)
|
(357)
|
(372)
|
(369)
|
(356)
|
(335)
|
(306)
|
(288)
|
(278)
|
(299)
|
(305)
|
(326)
|
(330)
|
(311)
|
(319)
|
(327)
|
(363)
|
(397)
|
(416)
|
(446)
|
(420)
|
(466)
|
(501)
|
(512)
|
(535)
|
(578)
|
(603)
|
(628)
|
(616)
|
(714)
|
|
Gross Profit |
370
N/A
|
380
+3%
|
390
+3%
|
425
+9%
|
446
+5%
|
465
+4%
|
472
+1%
|
460
-2%
|
465
+1%
|
509
+9%
|
490
-4%
|
500
+2%
|
473
-5%
|
442
-6%
|
435
-2%
|
438
+1%
|
428
-2%
|
438
+2%
|
436
-1%
|
453
+4%
|
465
+3%
|
462
-1%
|
533
+15%
|
581
+9%
|
590
+1%
|
631
+7%
|
697
+11%
|
728
+4%
|
841
+16%
|
906
+8%
|
954
+5%
|
1 037
+9%
|
1 090
+5%
|
1 154
+6%
|
1 211
+5%
|
1 271
+5%
|
1 284
+1%
|
1 319
+3%
|
1 298
-2%
|
1 326
+2%
|
1 406
+6%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(297)
|
(301)
|
(305)
|
(322)
|
(336)
|
(353)
|
(367)
|
(374)
|
(376)
|
(418)
|
(414)
|
(435)
|
(408)
|
(377)
|
(368)
|
(375)
|
(374)
|
(380)
|
(386)
|
(408)
|
(429)
|
(444)
|
(496)
|
(526)
|
(545)
|
(578)
|
(618)
|
(602)
|
(676)
|
(714)
|
(744)
|
(805)
|
(831)
|
(870)
|
(903)
|
(931)
|
(918)
|
(920)
|
(879)
|
(892)
|
(907)
|
|
Selling, General & Administrative |
(295)
|
(299)
|
(303)
|
(298)
|
(332)
|
(349)
|
(362)
|
(343)
|
(375)
|
(415)
|
(412)
|
(401)
|
(416)
|
(395)
|
(390)
|
(381)
|
(400)
|
(397)
|
(404)
|
(409)
|
(422)
|
(446)
|
(497)
|
(525)
|
(531)
|
(554)
|
(595)
|
(601)
|
(677)
|
(719)
|
(743)
|
(800)
|
(837)
|
(873)
|
(909)
|
(928)
|
(927)
|
(928)
|
(890)
|
(879)
|
(926)
|
|
Research & Development |
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
(5)
|
(21)
|
0
|
0
|
(11)
|
(25)
|
(21)
|
(27)
|
(26)
|
(25)
|
(29)
|
(30)
|
(30)
|
(29)
|
(31)
|
(33)
|
(42)
|
(44)
|
(50)
|
(61)
|
(64)
|
(62)
|
(71)
|
(73)
|
(72)
|
(74)
|
(76)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(26)
|
0
|
|
Other Operating Expenses |
(2)
|
(2)
|
(2)
|
(0)
|
(3)
|
(3)
|
(4)
|
0
|
(1)
|
(4)
|
(2)
|
0
|
8
|
17
|
27
|
39
|
26
|
18
|
30
|
42
|
14
|
29
|
27
|
41
|
15
|
6
|
7
|
43
|
32
|
38
|
41
|
55
|
56
|
64
|
70
|
80
|
80
|
81
|
84
|
87
|
95
|
|
Operating Income |
73
N/A
|
79
+8%
|
85
+8%
|
103
+21%
|
110
+7%
|
113
+2%
|
105
-7%
|
87
-18%
|
89
+3%
|
90
+2%
|
75
-17%
|
65
-14%
|
65
0%
|
65
+0%
|
67
+3%
|
63
-6%
|
53
-15%
|
58
+9%
|
50
-14%
|
45
-11%
|
37
-18%
|
18
-51%
|
36
+100%
|
56
+53%
|
44
-20%
|
53
+19%
|
79
+50%
|
126
+59%
|
166
+32%
|
192
+16%
|
209
+9%
|
232
+11%
|
259
+12%
|
284
+10%
|
308
+8%
|
339
+10%
|
366
+8%
|
398
+9%
|
420
+5%
|
434
+3%
|
499
+15%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(5)
|
(7)
|
(7)
|
(8)
|
(1)
|
(7)
|
(7)
|
(7)
|
(16)
|
(11)
|
(13)
|
(17)
|
(20)
|
(1)
|
(5)
|
(2)
|
(1)
|
(17)
|
(16)
|
(18)
|
(16)
|
(16)
|
(14)
|
(11)
|
(9)
|
(7)
|
(6)
|
(4)
|
(5)
|
(4)
|
0
|
5
|
11
|
14
|
12
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(0)
|
(0)
|
0
|
(10)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
1
|
(9)
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
2
|
2
|
2
|
2
|
(0)
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
23
|
23
|
24
|
21
|
21
|
27
|
27
|
27
|
25
|
28
|
33
|
44
|
23
|
28
|
16
|
20
|
18
|
1
|
3
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(3)
|
(3)
|
(2)
|
(2)
|
(13)
|
(13)
|
(14)
|
(2)
|
(12)
|
|
Pre-Tax Income |
95
N/A
|
101
+6%
|
106
+6%
|
121
+13%
|
127
+5%
|
134
+5%
|
127
-5%
|
105
-17%
|
107
+2%
|
111
+3%
|
107
-3%
|
95
-11%
|
81
-15%
|
86
+7%
|
67
-22%
|
61
-8%
|
59
-4%
|
43
-28%
|
33
-21%
|
32
-5%
|
32
+2%
|
17
-49%
|
37
+122%
|
29
-20%
|
29
-2%
|
36
+25%
|
62
+73%
|
109
+76%
|
151
+38%
|
180
+19%
|
200
+11%
|
222
+11%
|
251
+13%
|
277
+10%
|
300
+9%
|
324
+8%
|
355
+10%
|
393
+11%
|
419
+7%
|
447
+7%
|
500
+12%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(10)
|
(11)
|
(11)
|
(14)
|
(14)
|
(15)
|
(15)
|
(12)
|
(12)
|
(13)
|
(12)
|
(13)
|
(11)
|
(14)
|
(10)
|
(8)
|
(8)
|
(5)
|
(5)
|
(6)
|
(6)
|
(2)
|
(6)
|
(5)
|
(5)
|
(6)
|
(8)
|
(14)
|
(20)
|
(24)
|
(29)
|
(30)
|
(33)
|
(36)
|
(35)
|
(39)
|
(43)
|
(48)
|
(55)
|
(56)
|
(64)
|
|
Income from Continuing Operations |
85
|
90
|
95
|
107
|
113
|
118
|
112
|
94
|
95
|
98
|
96
|
82
|
69
|
72
|
56
|
53
|
51
|
38
|
29
|
26
|
27
|
14
|
30
|
24
|
24
|
30
|
54
|
95
|
131
|
156
|
170
|
192
|
218
|
241
|
266
|
286
|
312
|
345
|
364
|
391
|
435
|
|
Income to Minority Interest |
0
|
0
|
(1)
|
(4)
|
(6)
|
(8)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(8)
|
(8)
|
(7)
|
(6)
|
(9)
|
(5)
|
(4)
|
(1)
|
3
|
2
|
2
|
(1)
|
(5)
|
(7)
|
(10)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(13)
|
(11)
|
(9)
|
(8)
|
(8)
|
(8)
|
|
Net Income (Common) |
85
N/A
|
90
+6%
|
94
+5%
|
103
+10%
|
107
+4%
|
111
+3%
|
103
-7%
|
85
-18%
|
85
+1%
|
88
+3%
|
86
-2%
|
72
-16%
|
59
-18%
|
63
+6%
|
49
-22%
|
45
-8%
|
44
-3%
|
32
-28%
|
20
-37%
|
21
+5%
|
23
+8%
|
14
-39%
|
34
+146%
|
26
-24%
|
26
+0%
|
29
+12%
|
49
+71%
|
89
+80%
|
122
+37%
|
145
+19%
|
158
+9%
|
179
+14%
|
204
+14%
|
228
+11%
|
252
+11%
|
273
+8%
|
302
+11%
|
336
+11%
|
356
+6%
|
383
+8%
|
428
+12%
|
|
EPS (Diluted) |
0.15
N/A
|
0.16
+7%
|
0.17
+6%
|
0.19
+12%
|
0.2
+5%
|
0.2
N/A
|
0.18
-10%
|
0.15
-17%
|
0.14
-7%
|
0.15
+7%
|
0.15
N/A
|
0.12
-20%
|
0.11
-8%
|
0.11
N/A
|
0.08
-27%
|
0.07
-13%
|
0.06
-14%
|
0.04
-33%
|
0.03
-25%
|
0.03
N/A
|
0.04
+33%
|
0.03
-25%
|
0.06
+100%
|
0.04
-33%
|
0.05
+25%
|
0.05
N/A
|
0.08
+60%
|
0.15
+88%
|
0.19
+27%
|
0.23
+21%
|
0.25
+9%
|
0.29
+16%
|
0.34
+17%
|
0.37
+9%
|
0.41
+11%
|
0.45
+10%
|
0.43
-4%
|
0.47
+9%
|
0.52
+11%
|
0.55
+6%
|
0.61
+11%
|